Home / Health / New GLP-1 Pills: Easier But Less Potent?
New GLP-1 Pills: Easier But Less Potent?
15 Jun
Summary
- New oral GLP-1 medications are now available, offering an alternative to injections.
- Pill versions may be less effective for weight loss than injectable counterparts.
- Oral GLP-1s show promise for type 2 diabetes management with potentially more side effects.
Popular GLP-1 medications, known for significant weight loss, have expanded with new oral pill formulations from Eli Lilly and Novo Nordisk. These offer a needle-free alternative to injections like Ozempic, Wegovy, Mounjaro, and Zepbound.
While convenient, the efficacy of these new pills in clinical trials indicates they are less potent for weight loss compared to their injectable forms. For instance, one study showed an average loss of about 25 pounds with an oral GLP-1, versus up to 50 pounds with injections.
For individuals managing type 2 diabetes, oral versions may offer better blood sugar control, though weight loss results may differ. Furthermore, studies suggest a higher risk of discontinuing treatment due to side effects with oral semaglutide compared to its injectable form. Costs for both oral and injectable GLP-1s can start at $25 per month with insurance, but self-pay prices vary significantly, ranging from $149 to $449 per month.
